Literature DB >> 17998352

Targeting improvements in asthma morbidity in Chicago: a 10-year retrospective of community action.

John Jay Shannon1, Catherine D Catrambone, Lenore Coover.   

Abstract

Chicago has been described as "asthma ground zero" due to its disproportionately high rates of asthma-related hospitalization and mortality. Asthma prevalence rates in Chicago are higher for whites and African Americans than the national average. In an effort to address the asthma burden and disparities in Chicago, multiple initiatives throughout the city have been launched and continue due largely to the support of the Otho S.A. Sprague Memorial Institute. The purpose of this article is to describe the policy, advocacy, educational, surveillance, research, quality improvement, community, and consortia activities over the past 10 years and their impact on asthma morbidity and disparities in Chicago.

Entities:  

Mesh:

Year:  2007        PMID: 17998352     DOI: 10.1378/chest.07-1923

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  The burden of asthma in the Chicago community fifteen years after the availability of national asthma guidelines: the design and initial results from the CHIRAH study.

Authors:  Kevin B Weiss; John Jay Shannon; Laura S Sadowski; Lisa K Sharp; Laura Curtis; Christopher S Lyttle; Rajesh Kumar; Madeleine U Shalowitz; Lori Weiselberg; Catherine D Catrambone; Arthur Evans; Romina Kee; Jon Miller; Linda Kimmel; Leslie C Grammer
Journal:  Contemp Clin Trials       Date:  2009-01-23       Impact factor: 2.226

2.  A computable phenotype for asthma case identification in adult and pediatric patients: External validation in the Chicago Area Patient-Outcomes Research Network (CAPriCORN).

Authors:  Majid Afshar; Valerie G Press; Rachel G Robison; Abel N Kho; Sindhura Bandi; Ashvini Biswas; Pedro C Avila; Harsha Vardhan Madan Kumar; Byung Yu; Edward T Naureckas; Sharmilee M Nyenhuis; Christopher D Codispoti
Journal:  J Asthma       Date:  2017-11-10       Impact factor: 2.515

3.  Protease-activated receptor 2 activation of myeloid dendritic cells regulates allergic airway inflammation.

Authors:  Ian P Lewkowich; Scottie B Day; John R Ledford; Ping Zhou; Krista Dienger; Marsha Wills-Karp; Kristen Page
Journal:  Respir Res       Date:  2011-09-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.